Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - cyclophosphamide monohydrate - oral tablet - 50mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - cyclophosphamide monohydrate - oral tablet - 50mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - cyclophosphamide monohydrate - oral tablet - 50mg

САЩ - английски - NLM (National Library of Medicine)

roxane laboratories, inc. - cyclophosphamide (unii: 8n3dw7272p) (cyclophosphamide - unii:8n3dw7272p) - tablet - 25 mg - cyclophosphamide tablets, although effective alone in susceptible malignancies, are more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible to cyclophosphamide treatment: - malignant lymphomas (stages iii and iv of the ann arbor staging system), hodgkin’s disease, lyphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, burkitt’s lymphoma. - multiple myeloma. - leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia; acute lymphoblastic (stem-cell) leukemia in children (cyclophosphamide given during remission is effective in prolonging its duration). - mycosis fungoides (advanced disease). - neuroblastoma (disseminated disease). - adenocarcinoma of the ovary. - retinoblastoma. - carcinoma of the breast. cyclophosphamide tablets are useful in carefully selected cases of biopsy proven “minimal c

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - cyclophosphamide monohydrate - powder for solution for injection - 2gram

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - cyclophosphamide monohydrate - powder for solution for injection - 1gram

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - cyclophosphamide monohydrate - powder for solution for injection - 500mg

Малта - английски - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - cyclophosphamide monohydrate - powder for solution for injection - cyclophosphamide monohydrate 1000 mg - antineoplastic agents

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - cyclophosphamide monohydrate - powder for solution for injection - 500mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - cyclophosphamide monohydrate - powder for solution for injection - 1gram